Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

PURPOSE/BACKGROUND: This post hoc analysis examined the time point at which clinically significant improvement in major depressive disorder (MDD) symptoms occurs with desvenlafaxine versus placebo. METHODS: Data were pooled from 9 short-term, double-blind, placebo-controlled studies in adults with M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Psychopharmacol
Main Authors: Katzman, Martin A., Nierenberg, Andrew A., Wajsbrot, Dalia B., Meier, Ellen, Prieto, Rita, Pappadopulos, Elizabeth, Mackell, Joan, Boucher, Matthieu
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Original Contributions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596832/
https://ncbi.nlm.nih.gov/pubmed/28817491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados